This study is in progress, not accepting new patients
Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis
Summary
- Eligibility
- for people ages 18-64 (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Najwa Elnachef
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Najwa Elnachef
Associate Professor, Medicine. Authored (or co-authored) 16 research publications. Research interests: Fecal Microbiota Transplant · Intestinal Microbiome · Celiac Disease · Inflammatory Bowel Disease · Balloon Assisted Enteroscopy.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Najwa Elnachef
- ID
- NCT03006809
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated